Show Me Listing

Online Ebooks (PDF) Library

• Home
• Popular
• Latest
• Contact

Home » Industries » Pharmaceutical Industry

Compliance Through Science: US Pharmaceutical Industry Experts on ...

Source: www.stimson.org
Topic: Pharmaceutical Industry

Sort Desciption: pharmaceutical company, 10 August 2002. Other industry experts held the Nuclear Regulatory Commission’s transfer, access, ...

Content Inside: Compliance Through Science: US Pharmaceutical Industry Experts on a Strengthened Bioweapons Nonproliferation Regime A Collaborative Research Report of Experts from the US Pharmaceutical and Biotechnology Industries Report No. 48 September 2002 Copyright©2002 11 Dupont Circle, NW Ninth Floor Washington, DC 20036 phone 202.223.5956 fax 202.238.9604 www.stimson.org email: info@stimson.org Preface and Acknowledgements This report materialized through a collaboration of several individuals, namely ten top-notch experts from the US pharmaceutical and biotechnology industries and the staff of the Stimson Center’s Chemical and Biological Weapons Nonproliferation Project. The industry experts graciously accepted the Stimson Center’s invitation to examine the proposals that the US government advanced in the fall of 2001 to substitute for a legally binding, multilateral monitoring protocol to the Biological and Toxin Weapons Convention (BWC). Recognizing that some of the brightest scientific minds in the countries reside within the US private sector and appreciating fully the significant impact that experts from the US chemical industry had in shaping the Chemical Weapons Convention, the Stimson Center sought to tap this expertise to sanity check the approach that the US government has advocated to strengthen the international regime against germ weapons. The project is indebted to the industry participants who voluntarily detoured from their busy schedules to attend meetings and review the draft report. The industry experts who can be acknowledged by name are, in alphabetical order, Dr. Robert Goldberg, a thirty-year veteran of US industry and the National Cancer Institute; Dr. Robert Hamilton; senior scientist and group leader at a large US biotechnology firm; Dr. Jennie Hunter-Cevera, who brought extensive industry experience to her current position as president of the University of Maryland Biotechnology Institute; Mr. Douglas Jaeger, recently retir ...

©2007 Show Me Listing - Designed by Free CSS Templates

RSS Feed Sitemap Privacy Policy